Alembic Pharmaceuticals Limited

APLLTD.NS·NSE·Healthcare
Compare
787.05−3.30 (−0.42%)today
As of Oct 21, 2:11 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close790.35
Open794.20
Day range781.30794.70
52-week range635.80998.00
Off day high−0.96%
Off 52-week high−21.14%
Volume45.34K
Avg. volume (3M)157.42K
Market cap154.71B
EPS (TTM)35.27
Forward P/E16.08
P/E ratio (TTM)22.31
Dividend yield1.52% (12.00)
Beta (5Y)0.32
Shares outstanding196.56M
Short interest—
Earnings dateAug 6, 2025 (est.)
Analyst target961.80
Profit margin8.91%

Against its peers

Compare in full ›
APLLTD.NS ALKEM.NS AUROPHARMA.NS AKUMS.NS GRANULES.BO IPCALAB.BO
Market cap 154.71B 599.62B 908.41B 106.41B 194.90B 486.30B
P/E (TTM) 22.3 27.8 24.7 36.5 35.7 37.1
Forward P/E 16.1 22.4 16.9 20.4 26.8 27.2
Price/book 2.7 4.3 2.4 3.2 4.9 6.0
Dividend yield 1.52% 0.40% — 0.14% 0.26% 0.33%
1-year change −15.27% −9.58% +47.52% +50.86% +0.63% +42.82%
Today −0.42% +0.22% −2.63% −2.05% −0.43% +5.60%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

InvestyWise·Positive

Alembic Pharmaceuticals: Gets USFDA Approval for Otic Suspension

InvestyWise delivers real-time Indian stock market news, corporate filings, regulatory disclosures, and financial analysis. Track NSE and BSE-listed companies with AI-powered insights for smarter investment decisions. Alembic…

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.